Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C lookback.

M Goldman1, G Spurll

  • 1Héma-Québec, Saint-Laurent, Canada. mgoldman@hema-quebec.qc.ca

Current Opinion in Hematology
|October 31, 2000
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) screening significantly reduced posttransfusion hepatitis. Identifying recipients of contaminated blood through lookback programs is crucial for preventing long-term complications like cirrhosis and cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis.

Journal of clinical apheresis·2003
Same author

Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs.

Journal of perinatology : official journal of the California Perinatal Association·2001
Same author

Outcome of pregnancy in women with hereditary thrombophilia.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2001
Same author

Targeted hepatitis C lookback: Quebec, Canada.

Transfusion·1999
Same author

Hepatitis C lookback.

Transfusion medicine reviews·1998
Same author

PEL, a 'new' high-frequency red cell surface antigen.

Vox sanguinis·1996
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) was a leading cause of posttransfusion hepatitis before specific donor screening.
  • HCV infection can lead to severe long-term health issues, including cirrhosis and hepatocellular carcinoma, often decades after initial infection.

Purpose of the Study:

  • To highlight the importance of blood donor screening for Hepatitis C.
  • To discuss the implementation and challenges of blood recipient lookback programs.
  • To emphasize the need for improved blood product tracking systems.

Main Methods:

  • Review of historical data on posttransfusion hepatitis.
  • Analysis of current lookback strategies (targeted and general) in multiple countries.
  • Discussion of the limitations and potential improvements in blood product traceability.

Related Experiment Videos

Main Results:

  • Introduction of HCV screening drastically reduced transfusion-associated hepatitis.
  • Lookback programs, while valuable, face logistical and practical difficulties.
  • Vein-to-vein tracking and centralized registries offer potential solutions for enhanced safety.

Conclusions:

  • Effective screening and robust lookback protocols are essential for public health.
  • Improved traceability of blood products is necessary to safeguard recipients.
  • Continued vigilance and system improvements are vital in preventing transfusion-transmitted HCV.